🇨🇦 Dihydroartemisinin Piperaquine in Canada

Dihydroartemisinin Piperaquine (Dihydroartemisinin Piperaquine) regulatory status in Canada.

Marketing authorisation

Dihydroartemisinin Piperaquine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Dihydroartemisinin Piperaquine approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Dihydroartemisinin Piperaquine in Canada?

Stanford University is the originator. The local marketing authorisation holder may differ — check the official source linked above.